Copernicus Capital Management as of Sept. 30, 2019
Portfolio Holdings for Copernicus Capital Management
Copernicus Capital Management holds 16 positions in its portfolio as reported in the September 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Gilead Sciences (GILD) | 11.7 | $13M | 198k | 63.38 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 10.2 | $11M | 65k | 169.42 | |
| Bristol Myers Squibb (BMY) | 9.3 | $10M | 198k | 50.71 | |
| Abbvie (ABBV) | 9.3 | $10M | 132k | 75.72 | |
| BioMarin Pharmaceutical (BMRN) | 8.5 | $9.2M | 136k | 67.40 | |
| Iqvia Holdings (IQV) | 8.1 | $8.7M | 58k | 149.38 | |
| Thermo Fisher Scientific (TMO) | 7.8 | $8.4M | 29k | 291.28 | |
| Humana (HUM) | 7.4 | $7.9M | 31k | 255.68 | |
| Centene Corporation (CNC) | 5.9 | $6.4M | 147k | 43.26 | |
| Merck & Co (MRK) | 5.8 | $6.2M | 74k | 84.18 | |
| Caredx (CDNA) | 3.9 | $4.2M | 185k | 22.61 | |
| Zoetis Inc Cl A (ZTS) | 3.5 | $3.8M | 30k | 124.58 | |
| Illumina (ILMN) | 2.6 | $2.8M | 9.3k | 304.21 | |
| Amicus Therapeutics (FOLD) | 2.5 | $2.7M | 335k | 8.02 | |
| Sientra | 2.3 | $2.5M | 385k | 6.48 | |
| Fate Therapeutics (FATE) | 1.1 | $1.2M | 75k | 15.53 |
